Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. [electronic resource]
Producer: 20190409Description: 210-216 p. digitalISSN:- 1532-6535
- Antimetabolites, Antineoplastic -- administration & dosage
- Capecitabine -- administration & dosage
- Clinical Decision-Making
- Dihydrouracil Dehydrogenase (NADP) -- genetics
- Drug Dosage Calculations
- Fluorouracil -- administration & dosage
- Genotype
- Humans
- Patient Selection
- Pharmacogenetics -- standards
- Pharmacogenomic Testing -- standards
- Pharmacogenomic Variants
- Phenotype
- Precision Medicine -- standards
- Predictive Value of Tests
No physical items for this record
Publication Type: Journal Article; Practice Guideline; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.